NCT02655133View on ClinicalTrials.gov

Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 1, 2018

Study Completion Date

January 1, 2018

Conditions
Severe SepsisSeptic Shock
Interventions
DRUG

Pentaglobin®

Immunoglobulins that will be used are IgM enriched and will be infused at 5 ml/Kg/day for 3 days.

DRUG

Physiologic solution

Physiologic solution will be infused and will be infused at 5 ml/Kg/day for 3 days.

Trial Locations (1)

60126

University ICU, AOU Ospedali Riuniti Ancona, Torrette Di Ancona

All Listed Sponsors
lead

Università Politecnica delle Marche

OTHER

NCT02655133 - Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients. | Biotech Hunter | Biotech Hunter